Magen BioSciences, Inc., a specialty dermatology company, today announced the appointment of Alexa Boer Kimball, M.D. MPH, Associate Professor Harvard Medical School, to its scientific advisory board (SAB).
“The addition of Dr. Kimball to our scientific advisory board is an important step in the growth of our company,” said Brian Gallagher, Ph.D., Magen’s president and chief executive officer. “As a researcher specializing in the design and execution of clinical trials, her extensive experience will greatly help Magen advance the company’s mission to identify and develop therapeutic treatments for several dermatological diseases. We are proud to add her to the already impressive roster of scientists who are members of the Magen scientific advisory board.”
Dr. Kimball is currently director of CURTIS, the joint Clinical Unit for Research Trials in Skin at Massachusetts General Hospital and Brigham and Women’s Hospital at Harvard Medical School in Boston. Dr. Kimball runs an active unit including phase 1 through phase 4 studies in diverse areas using topical and systemic agents for skin diseases. She has also done extensive research in the areas of physician workforce and quality of life.
A respected leader in skin research, Dr. Kimball received her medical degree from the Yale University School of Medicine in New Haven, Connecticut, after obtaining bachelor’s degrees in molecular biology and public and international affairs from Princeton University. Her postgraduate work included an internship at Beth Israel Hospital/Harvard University in Boston, Massachusetts, and residency in dermatology at the Stanford University School of Medicine in Stanford, California, where she also served as Chief Resident. Following her residency, Dr. Kimball went on to complete a clinical research fellowship in dermatology at the National Institutes of Health in Bethesda, Maryland, and she concurrently obtained an MPH with a focus on clinical trials from the Johns Hopkins School of Public Health.
Dr. Kimball also holds a number of major national appointments, including Chair of the Society for Investigative Dermatology’s Committee on External Relations and Chair of the Membership Committee for the American Academy of Dermatology.
About Magen BioSciences
Magen BioSciences was founded in 2006 by an outstanding group of scientists and investors to build a science-based dermatology company. The company is a research and development stage enterprise that acquires and develops novel and proprietary technologies and is headquartered in Waltham, Massachusetts.